MVIS is spiking due to a contact for 14M worth of components
for a
fortune 100 company. Co just received 8M as a licensing fee as part
of the contract. Price has broken above multi-year resistance of
$3.5 and is now fading off as per the overall market.
Potential BUY
GBSN is a 14M company and recent IPO. Stock up on a video conference, transcript basically read like a hyped up PR with tonnes of forward looking statement. Co admitted their stock "awareness" is of high priority and also did a financing on the 6th of March. Potential SHORT.
HQCL is up on news they've opened a credit facility with Wells Fargo. Tonnes of overhead resistance, market cap is unknown, key stats don't add up, seems sketchy...Potential SHORT
GMAN is up on earnings yet earnings is going down each year with this year being down significantly. Co has 7M cash and 41M in debt. Technically the chart has a tonne of overhead resistance, potential SHORT.
ORMP is a paid pump by http://tickerresearch.com. Potential SHORT ideally once 6 cracks.
ADXS, CORT are biotech stocks spiking. ADXS is stuck in a channel between 12 & 14. Both are potential SHORTS. If ADXS can break 14.5 it's a potential b/o BUY as shorts are likely to get squeezed.
JUST WATCHING...
NVGN - Up on positive cancer treatment news......Interesting to see how
this one plays out. Historically stock has never held it's gains.
No comments:
Post a Comment